<unk>  is an antiemetic drug. In the United States, the combination drug<unk> /palonosetron (trade name Akynzeo) is approved by the Food and Drug Administration for prevention of acute and delayed chemotherapy-induced nausea and vomiting, including highly emetogenic chemotherapy such as with cisplatin. In Europe, it is approved by the European Medicines Agency (EMA) for the same indication.
Netupitant
Oprelvekin
Aprepitant
Bosentan
Macitentan
Ezlopitant
Eptifibatide
Tafamidis